GW

GW Vitek CO.,LTD.

Specializes in biotechnology solutions and scientific instruments for R&D.

036180 | KO

Overview

Corporate Details

ISIN(s):
KR7036180008
LEI:
Country:
South Korea
Address:
서울특별시 금천구 벚꽃로 244 1101호(가산동, 벽산디지털밸리5차), 서울특별시

Description

GW Vitek CO.,LTD. is a company specializing in biotechnology solutions and scientific instruments for research and development. The company operates through two primary segments. The Bio Business division focuses on the development, manufacturing, and sale of bio-related products, including research antibodies and comprehensive biotechnology solutions. The Scientific Equipment division provides a wide range of laboratory instruments and consumables. Key product areas include imaging systems, chromatography equipment and consumables, general laboratory products, and tools for metabolic analysis. GW Vitek aims to supply researchers with optimal solutions to support the entire workflow for R&D and quality control analysis across various industries.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
기타경영사항(자율공시) (회생회사 지더블유바이텍 주식회사 M&A 공고)
Korean 10.7 KB
2025-09-05 00:00
[기재정정]회생절차개시결정
Korean 13.0 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.3 MB
2025-08-14 00:00
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.5 KB
2025-08-13 00:00
[기재정정]사업보고서 (2024.12)
Korean 1.8 MB
2025-08-06 00:00
[기재정정]회생절차개시결정
Korean 12.6 KB
2025-07-04 00:00
[기재정정]감자결정(자회사의 주요경영사항)
Korean 19.2 KB
2025-06-10 00:00
감자결정(자회사의 주요경영사항)
Korean 14.6 KB
2025-06-04 00:00
[기재정정]회생절차개시결정
Korean 12.2 KB
2025-05-27 00:00
불성실공시법인지정
Korean 7.7 KB
2025-05-26 00:00
[기재정정]회생절차개시결정
Korean 12.2 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.2 MB
2025-04-29 00:00
불성실공시법인지정예고 (공시번복 2건)
Korean 6.3 KB
2025-04-10 00:00
기타시장안내 (상장폐지 관련 이의신청서 접수 및 개선기간 부여)
Korean 3.9 KB
2025-04-10 00:00
주권매매거래정지기간변경 (개선기간 부여)
Korean 5.2 KB

Automate Your Workflow. Get a real-time feed of all GW Vitek CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GW Vitek CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GW Vitek CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.